| 4 Small Cap Biotechs To Keep an Eye On The Inflection Point submits: Biotech stocks are a long-time favorite of investors, especially during bear markets, due to their catalytic nature which tends to be resistant to the vagaries of the macro-economic climate. With this in mind, we have been tracking a number of biotech companies with the potential for positive FDA decisions in the coming weeks and months. Should any of these companies receive FDA approval, their stocks should see substantial moves to the upside. Here are a few of our most compelling ideas in the biotech space: Affymax Inc. (AFFY)Complete Story » seekingalpha.com |
St. Jude Says Ex-Executive Violated Pact by Joining Medtronic St. Jude Medical believes a former top executive with access to "copious amounts" of confidential information violated an employment agreement by leaving and quickly joining heart-device rival Medtronic. online.wsj.com |
Boston Scientific Resolves FDA Warning Letter Boston Scientific it has finally resolved a corporate warning letter the FDA issued in early 2006 after finding problems at company plants. online.wsj.com |
Alzheimer’s Foundation of America Telethon - Video Alzheimer's Foundation of America to Hold Inaugural 'Together for Care' Telethon feedproxy.google.com |
New York City Audience Applauds Speech By Cannabis Science CEO Dr. Robert Melamede at 'The Marijuana Conference;' CFO Richard Cowan on Panel Moderated by CNBC Anchor Trish Regan for New Program to Air In Early December Also Covered By Disco [PR Newswire] - Cannabis Science, Inc. , a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to report that the audience at "the first non-biased event in the industry" loudly cheered the speech by Cannabis Science CEO Dr. us.rd.yahoo.com |